Malvern unveils improved particle size analyser
Malvern has launched a new generation Spraytec system for particle size analysis of aerosols and sprays.
Archives for September 4, 2005
Magnets make catalyst recovery a cinch
Researchers have developed a way of recovering catalysts used in the manufacture of pharmaceuticals using simple magnets, potentially doing away with the need for complex separation and purification steps.
GSK invests further in flu vaccine capacity
GlaxoSmithKline has acquired a manufacturing facility in the USA from Wyeth, and will invest at least $100 million (€80m) to develop and produce flu vaccines at the site using new tissue culture technology.
Metrohm launches improved Gentamicin detector
Chemical analysis specialists, Metrohm, have introduced its latest ion chromatography system, which enables Gentamicin determination without the complex set up that is characteristic of the current HPLC method.
Novartis offers $4.5bn for control of Chiron
Novartis has offered to buy the remaining shares it does not already own in US headquartered Chiron for $4.5 billion, laying to rest speculation in the marketplace that it had been eyeing up Germany's Schering AG.
Biogenerics dethrones blockbusters, report claims.
With blockbuster patents set to expire, the biogenerics market is set to cash in as previous challenges such as a lack of regulatory framework are nearing resolve, particularly in Western Europe.
Researchers identify molecular anchor in CNS infection
Researchers in the US have identified a molecular version of an anchor, which allows the access of bacteria into the central nervous system. By blocking the molecules anchoring ability, its potential importance as a drug target may hold the key to...
New method identifies high cholesterol gene
A new study, which uses a new method in identifying the specific gene involved in high cholesterol has been hailed as, "a landmark publication." The study also describes the potential to use this approach in forming a treatment to address the causes...
Novartis' Chiron acquisition beefs up vaccine division
Following hot on the heels of the GSK's expansion of its vaccine division, Novartis is seeking to take control of vaccine maker Chiron by buying the remaining shares it does not already own in the US firm for $4.5bn (£2.5bn).
Indian biotech to build plant in Malaysia
India's leading biotechnology company, Bharat Biotech, has said it intends to spend more than €10 million on the construction of a manufacturing facility in Perak, Malaysia, to mass produce hepatitis B, typhoid and malaria vaccines.